Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. A Randomized Trial With Magnetic Resonance Spectroscopy.

NCT00505167 is registered in ClinicalTrials.gov with Hospital Miguel Servet as lead sponsor.

NCT NCT00505167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00505167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. A Randomized Trial With Magnetic Resonance Spectroscopy.
Lead sponsor
Hospital Miguel Servet
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
December 31, 2008
Enrollment
64 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, alzheimer type